Search

everythinglearnresearchcommunity

for

Search:↓

Young women in West Bengal, India, with PCOS often have estrogen resistance, leptin receptor issues, folate deficiency, T2DM, and acanthosis, commonly linked to obesity.

Many COVID-19 patients have long-term symptoms, especially women, but certain medications may help reduce these symptoms.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

COVID-19 vaccines may cause hair loss in people who are genetically prone to it.

Thai rice bran extracts, especially from Tubtim Chumphae rice, can significantly reduce the activity of hair loss genes, with x-tocopherol showing potential as an anti-hair loss product.

University students in Egypt experienced high stress during COVID-19's third wave, with negative coping mechanisms being more common.

Topical spironolactone may help treat ocular graft-versus-host disease with minimal side effects.

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

COVID-19 can cause various skin issues, including rashes and 'COVID toes', and may worsen autoimmune diseases or affect men with baldness more severely.

Copper deficiency is linked to post-COVID-19 hair loss in women.

Recent selection on immune response genes was identified across seven ethnicities.

Older adults in Vietnam often experience hair loss after COVID-19, especially women, singles, and those hospitalized.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

Social media data can help track and predict COVID-19 symptoms and trends.

During the COVID-19 pandemic, some skin conditions became more common while others decreased.

Many patients with hair loss had low iron and vitamin D levels, but thyroid issues were not common.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Pregnant women with COVID-19 and gestational diabetes may face severe complications, and more research is needed on their outcomes.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

During the COVID-19 pandemic in Turkey, the most common skin problem for both kids and adults was acne.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

The treatment improved hair growth and thickness in patients with hair loss, even 10 months after therapy without additional products.

The COVID-19 pandemic led to an increase in untreated hair diseases and showed the importance of teledermatology.

Having a lot of gray hair and hair loss are linked to more severe COVID-19.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

Dermatologists helped identify COVID-19 through skin symptoms and managed skin issues during the pandemic, but more high-quality research is needed.

Certain Dibenzo derivatives may help treat prostate cancer.